Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevonescein for Nerve and Ureter Visualization in Minimally Invasive Surgery
NCT06662097Phase 2Completed
- Sponsor
- Alume Biosciences
- Start
- Oct 2024
- Primary completion
- Jan 2026
- Modality
- Small Molecules, Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of bevonescein in nerve injury, sponsored by Alume Biosciences. Started Oct 2024; status: completed.
02
Drugs
bevonescein
03
Conditions
nerve injury
Beyond the preview
Go deeper on NCT06662097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06662097.